PKM and diabetes mellitus: Podocyte-specific PKM2-knockout mice with diabetes exhibited worse albuminuria and glomerular pathology than wild-type mice, while pharmacological activation of PKM2 reversed the elevation in toxic glucose metabolites and mitochondrial dysfunction induced by high glucose, which protected against DKD [36].